Neuropathy, Tremor, and a Reading Goal
Mr. Nakamura is 62 and has had type 2 diabetes for 24 years, with proliferative retinopathy treated by panretinal photocoagulation. Acuity is 20/60 OU with extensive field loss, and he reports disabling glare. He wants to read his granddaughter's letters and to manage his own insulin. He has severe peripheral neuropathy: the 10 g monofilament is not felt at any fingertip, and he has a mild intention tremor. He has never learned braille. He wears progressive lenses. He lives with his wife, who currently draws up his insulin.
1. Is braille a reasonable route to reading for him? Reason through the specific factors rather than answering in general terms.
Read the worked answer
For sustained reading, no - and the argument rests on his particulars, not on his age.
- Tactile sensitivity: absent 10 g monofilament perception at every fingertip is a poor foundation for discriminating dot patterns at reading speed. He could likely learn the alphabet and then fail to use it.
- Tremor: braille reading depends on smooth, light lateral scanning. An intention tremor degrades that even when sensation is intact.
- Acquisition timing: learning braille as a first-time adult reader of a code is slower, and his goal is letters from a grandchild, not a corpus of text.
- Acuity: at 20/60 with field loss and glare, large print with a task lamp and a yellow filter is still plausible for short personal letters.
What is defensible is a bounded tactile system: uncontracted braille or raised markings for a handful of insulin-related labels, accepted only if he demonstrates retention. Otherwise the better routes are a human reader, OCR on a phone with speech output, or large print - with glare control addressed first, since he named it. Note that field loss, not acuity, will govern how much text fits per line.
2. He wants to draw up and inject his own insulin. What is your risk hierarchy and what do you coordinate?
Read the worked answer
Highest risk: hypoglycemia and dosing error. Neuropathy affects his ability to feel injection sites and to distinguish vials by touch; the tremor affects drawing an accurate dose; field loss affects reading the syringe scale. Any one of these can produce a wrong dose.
Sequence of options:
- Remove the drawing step - pre-filled pens with audible or tactile clicks, or a pen with a large-print dose dial. This eliminates the most error-prone component outright.
- Speech output for glucose monitoring - a talking meter or a continuous glucose monitor with audible alerts. Confirm he can hear the alerts; do not assume.
- Rotation and site awareness - a systematic site map he can follow by habit, with a tactile or large-print body diagram, because reduced sensation means he will not notice lipohypertrophy.
- Wife as backup, not as default - his goal is independence, so her role should be verification with his consent rather than total substitution.
Coordinate with the diabetes educator, the pharmacist, and the prescriber. Insulin dosing is outside your scope to change; your contribution is the sensory and task-analysis side plus the equipment trial.
3. How would you evaluate whether the reading solution actually worked?
Read the worked answer
Measure the task, not the device.
- Granddaughter's letters: can he read a representative one, at what speed, for how long before fatigue, and with what comprehension? Test with a real letter, not a training passage.
- Glare: ask him to rate discomfort and to report how long he can sustain reading under his usual lighting before he stops.
- Independence: does he initiate reading without being prompted, and does he use the solution when you are not there?
- Insulin: correct dose drawn or dialed on three consecutive observed trials at home, no missed or doubled doses, and glucose logs reviewed with the educator.
If he abandons the device within two weeks, that is data - usually a mismatch between the task and the tool, or an unaddressed glare or hearing problem, not a motivation failure. Revise and retest rather than re-teach the same solution louder.